Table 2

Clinical characteristics of HIV-infected women (n=2,501)
n (%) Missing (%)
BMI (kg/m2) 1840 (73.6)
   <18.5 46 (7)
   18.5–24.9 401 (61)
   25–29.9 49 (7)
   ≥30 165 (25)
Vaginal wall abnormality 0 (0)
   None 2241 (90)
   Other1 260 (10)
VIA 0 (0)
   Negative 2344 (94)
   Positive 155 (6)
   Invasive cancer 2 (0)
Last CD4 count (per mm3) 365 (14.6)
   <300 490 (23)
   300–<450 560 (26)
   450–<650 592 (28)
   ≥650 494 (23)
WHO stage 1118 (44.7)
   Stage 1 1185 (86)
   Stage 2 104 (7)
   Stage 3 84 (6)
   Stage 4 10 (1)
ART regimen currently on2 1008 (40)
   TDF-containing ART3 778 (52)
   ZDV-containing ART4 600 (40)
   d4T-containing ART5 115 (8)

1Other includes discharge, lesion, warts, lesion and warts, warts and discharge, and other observations.

2All women were on ART, the regimen information here is based on those that were verified from clinical records.

3TDF: Tenofovir.

4ZDV: Zidovudine.

5d4T: Stavudine.

Ononogbu et al.

Ononogbu et al. BMC Public Health 2013 13:582   doi:10.1186/1471-2458-13-582

Open Data